Ennogen offers medicines, medical devices, unlicensed medicines, and OTC products.
Ennogen has raised $37.6M in total funding. The most recent round was Debt Financing. The last funding was announced in May 2024.
Ennogen's investors include Santander UK.
Ennogen is headquartered in Dartford, United Kingdom.
Ennogen offers medicines, medical devices, unlicensed medicines, and OTC products.
Ennogen is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ennogen — Funding & Investors." VCBacked, May 2, 2024, https://www.vcbacked.co/company/ennogen. Accessed August 14, 2026.
VCBacked. (2024). Ennogen — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ennogen
{{cite web |title=Ennogen — Funding & Investors |url=https://www.vcbacked.co/company/ennogen |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated